1. AEG Tumors
a. in metastastic disease - MSI-H/d-MMR (ICI), Her2+/neu (Trastuzumab), PDL-1 CPS/TAP (ICI), Claudin 18.2 (Zolbetuximab)
b. in Stadium IB-III, off-label use possible - Her2+/neu, PD1-PDL-1 CPS/TAP
1. AEG Tumors
a. in metastastic disease - MSI-H/d-MMR (ICI), Her2+/neu (Trastuzumab), PDL-1 CPS/TAP (ICI), Claudin 18.2 (Zolbetuximab)
b. in Stadium IB-III, off-label use possible - Her2+/neu, PD1-PDL-1 CPS/TAP
Formula:
Interpretation example: TPS 10% → 10% of tumor cells express PD-L1.
Interpretation example: CPS 20 → there are 20 PD-L1–positive cells (tumor + immune) for every 100 tumor cells.
Formula:
Interpretation example: TAP ≥ 10% → at least 10% of the tumor area (tumor cells or immune cells) is PD-L1–positive.
Systematic Approach:
1. Adequacy - A good smear shows fat, spicules, and cellular material.
2. Cellularity - Compare hematopoietic cells to fat spaces.
Age-related norms: Cellularity ≈ 100 – age (±10%) (e.g., 40-year-old → ~60% cellularity).
- Hypocellular (e.g., aplastic anemia, marrow suppression).
- Hypercellular (e.g., leukemia, myeloproliferative disorders).
3. E:M/ ratio: erythroid precursors : myeloid precursors ≈ 1:2 to 1:4
- E:M ↑Erythroid Hyperplasia: hemolysis, thalassemia
- E:M ↓Myeloid Hyperplasia/Erythroid Hypoplasia: infections, CML, myeloproliferative neoplasms
4. Erythropoesis:
- Maturation steps: Proerythroblasts → basophilic normoblasts → orthochromatic normoblasts.
- Abnormalities:
Dyserythropoiesis: multinuclearity, nuclear budding, irregular chromatin.
Increased erythropoiesis: hemolytic anemias, blood loss.
Decreased erythrpoiesis: aplastic anemia, marrow infiltration.
5. Myelopoiesis/Granulopoiesis:
- Maturation stages: myeloblasts → promyelocytes → myelocytes → metamyelocytes → bands → neutrophils.
- Look for:
Left shift (immature forms) → infections, leukemias.
Dysgranulopoiesis: hypolobation, hypogranularity.
Blasts >20% = acute leukemia (per WHO).
6. Megakaryopoesis: Normally present in small numbers, large cells with multilobed nuclei.
- Look for:
Increased: myeloproliferative neoplasms (e.g., essential thrombocythemia).
Decreased/absent: aplastic anemia, marrow failure.
Dysplastic forms: micromegakaryocytes, separated nuclei → myelodysplastic syndrome (MDS).
7. Other Cells
- Plasma cells: normally <5%. Increased in plasma cell disorders (e.g., multiple myeloma).
- Lymphocytes: scattered, small.
- Histiocytes/macrophages: may be seen with hemophagocytosis.
- Mast cells: few normally, increased in mastocytosis.
8. Special Features
- Blasts: count percentage (critical for leukemia diagnosis).
- Fibrosis: suggested if “dry tap” on aspiration → confirmed by biopsy.
- Infiltration: metastatic tumors, storage diseases (e.g., Gaucher cells).
- Iron stores (on Prussian blue stain)
a. Normal, increased (anemia of chronic disease), decreased (iron deficiency).
b. Ring sideroblasts → sideroblastic anemia, MDS.
Systemic approach:
Red Cells
1. Agglutination? - Hemolysis
2. Rouleux (Stacking)? - Indicative of Paraproteinemia (MM)
3. Nucleated Red Blood Cells? - Hemolysis/Bone marrow stress
4. Polychromasia (Increase in Reticulocytes) -Hemolysis/Blood loss (Increased Demand)/Response to Treatment (Ironsubs. in Iron Def. Anemia)
5. Quantity/Size - MCV, Anisocytosis?
6. Quality - Poikilocytosis
7. Red Cell Inclusions -
a. Howell jolly bodies (un-removed nucleus parts/Hyposplenism); normal in neonates; hemolysis and megalobastic anemia
b. Basophilic stippling (ribosomal RNA; best seen in Reticulocytes) - Hemoglobinopathy, MDS, Heavy Metal poisoning (Lead)
c. Pappenheimer bodies (Hemosiderin granules) - Postspelenectomy, Iron-overload, Sideroblastic anemia
d. Malaria
White Cells:
1. Quantity: estimate the Count, Differential
2. Quality: check, Nucleus+Cytoplasma - reactive?dysplasia?malignant population?
a. pleomorphic (reactive) vs monomorphic (malignant)
b. size - small/mature (as lymphocyte), medium (as monocyte), large/immature (as promyelocyte),
c. Nucleus to cytoplasma ratio (N/C) - high, moderate
d. Nucleus - immature/open/uncondensed/see-through chromatin (blasts) - mature/condensed chromatin/opaque (mature cells); cleft(visible groove)/cleaved(divided)/overlapping/indented -nucleus
e. Cytoplasma
- color: clear, pale grey (monocyte); faint basophilic (lymphocyte), deep basophilic (plasma cells)
- inclusions: granules, vacuoles, auer rods?
f. company? - other cytopenias/dysplasia/rouleaux/leukoerythrombastic/tear drops?
g. Lymphocytes - reactive/atypical (pleomorphic + abundant cytoplasma) vs malignant (monomorphic, high N/C)
h. Neutrophiles:
- toxic neutophilia: left shift, toxic granulation, toxic vacuolation, dohle bodies, WC count < 40
- hypo-/hypergranulation
- segments (normal 3-4 sausage like, joined by narrow bridge): hypersegmented (Medication - Hydroxycaramid, MTX; B12/Folic acid deficiency, Dysplasia, rarely Iron Deficiency), hyposegmented (such as pseudo-pelger-huet - Dysplasia) and Tacrolimus.
Platelets:
1. Quantity - estimate the count,
2. Quality - size variation, granulation